Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Kamil F Faridi,Hector Tamez,Neel M Butala,Eric A Secemsky,C Michael Gibson,Jordan B Strom,Jeptha P Curtis,Changyu Shen,Laura Mauri,Yang Song,Robert W Yeh

doi:10.1161/circulationaha.120.047729

Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Kamil F Faridi, Hector Tamez + Show 9 more

Open Access

PDF Available

https://doi.org/10.1161/circulationaha.120.047729

Copy DOI

Export

Save

Cite

Journal: Circulation	Publication Date: Jul 20, 2020
Citations: 8

Affiliation: Deaconess Hospital, Beth Israel Deaconess Medical Center, Yale University, Massachusetts General Hospital, Baim Institute for Clinical Research, Medtronic (United States)

#Beth Israel Deaconess Medical Center #Months Of Dual Antiplatelet Therapy #Dual Antiplatelet Therapy Study #Research In Cardiology #Dual Antiplatelet Therapy #National Cardiovascular Data Registry #Adjudicated Events #Department Of Medicine #Boston Scientific #Harvard Medical School

Abstract
Full-Text PDF
Similar Papers

Abstract

Listen

Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Full Text

Published Version (Free)

View/Download pdf

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Circulation

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.